Compare

ASP Isotopes Inc. vs Flexible Solutions International Inc vs Arq, Inc. vs Pure Bioscience, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearASP Isotopes Inc.
ASPI
Flexible Solutions International Inc
FSI
Arq, Inc.
ARQ
Pure Bioscience, Inc.
PURE
Year ended2025-12-312025-12-312025-12-312026-07-31
Revenue$23.85M$38.52M$120.34M$2.32M
Revenue growth (YoY)+475.5%+0.7%+10.4%+5.3%
Gross margin14.3%32.6%27.9% (computed)57.2%
Operating margin-251.2%11.9%-44.0%-89.9%
Net margin-670.2%2.0%-43.7%-107.1%
Net income-$159.84M$786.9K-$52.61M-$2.48M
EPS (Diluted)-$2.11$0.06-$1.27-$0.02
Operating cash flow-$37.78M$3.78M-$2.73M-$1.74M
Free cash flow-$47.43M-$591.7K-$11.31Mn/a
Cash & equivalents$285.60Mn/a$6.57M$569.0K
Total assets$498.02M$61.83M$230.58M$1.19M
Total liabilities$235.12M$19.00M$62.62M$7.59M
Shareholders' equity$204.15M$38.91M$167.96M-$6.40M
Return on year-end equity-78.3%2.0%-31.3%n/a
Shares outstanding111.68M12.72M42.73M130.02M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearASP Isotopes Inc.Flexible Solutions International IncArq, Inc.Pure Bioscience, Inc.
Latest$23.85M
Ended 2025-12-31
$38.52M
Ended 2025-12-31
$120.34M
Ended 2025-12-31
$2.32M
Ended 2026-07-31
1 year earlier$4.14M
Ended 2024-12-31
$38.23M
Ended 2024-12-31
$108.96M
Ended 2024-12-31
$2.20M
Ended 2025-07-31
2 years earlier$433.0K
Ended 2023-12-31
$38.32M
Ended 2023-12-31
$99.18M
Ended 2023-12-31
$1.96M
Ended 2024-07-31
3 years earlier$0
Ended 2022-12-31
$45.84M
Ended 2022-12-31
$102.99M
Ended 2022-12-31
$1.88M
Ended 2023-07-31
4 years earliern/a$34.42M
Ended 2021-12-31
$100.29M
Ended 2021-12-31
$1.85M
Ended 2022-07-31